ESR1 and breast cancer: The propensity of patients with ER+ disease to suffer bone metastasis, as well as the presence of DTCs in the bone marrow of breast cancer patients, suggests that DTCs in the bone may be the major source of CTCs and cell-free DNA shedding and may cause late relapse.